HRO Insight blog
Please visit NelsonHall's HRO Insight blog for further updates from our analysts daily
Cognizant - Quality Engineering
Vendor Analysis
published on Sep 25, 2024
Access to this report is restricted to logged in clients with access. Login to get full access
Report Overview:
This NelsonHall vendor assessment analyzes Cognizant's offerings and capabilities in quality engineering services
Who is this Report for:
NelsonHall’s Quality Engineering profile on Cognizant is a comprehensive assessment of Cognizant's offerings and capabilities, designed for:
- Sourcing managers monitoring the capabilities of existing suppliers of QE and identifying vendor suitability for quality engineering/QA/testing services
- Vendor marketing, sales, and business managers looking to benchmark themselves against their peers
- Financial analysts and investors specializing in the QE and IT services sectors.
Scope of this Report:
The report provides a comprehensive and objective analysis of Cognizant’s QE offerings, capabilities, and market and financial strengths, including:
- Identification of the company’s strategy, emphasis, and new developments
- Analysis of the company’s strengths, challenges, and outlook
- Revenue estimates
- Analysis of the company’s offerings and key service components
- Analysis of the company’s delivery organization, including the location of delivery centers.
Key Findings & Highlights:
Cognizant has grouped its testing capabilities within Quality Engineering & Assurance (QE&A). QE&A is a horizontal practice with P&L responsibility. The practice is at scale, with ~40k test practitioners, and is the largest QE practice globally. Cognizant highlights that its size gives it scale to invest.
Cognizant has strategically left QE&A’s structure unchanged in the past twenty years, while many of its competitors moved to a testing CoE structure, with testing delivery merged within larger, vertically aligned ADM groups. QE&A highlights that its structure brings a continued focus on testing and a consistent investment strategy.
QE&A highlights its current service and IP priorities:
- Cognizant Continuous Testing Platform
- Neuro AI for QA, which groups AI use cases as part of the corporate Neuro AI initiative
- Skygrade, for cloud migration
- E2E automated testing for phygital: a combination of software and hardware devices for processes involving hardware such as connected devices, ATMs, vehicle UIs, and medical devices
- Smart V&V: GenAI regulatory compliance, for example, for medical device manufacturers, life science, and financial services, and across Europe, for meeting EU regulations. In addition, QE&A has a GenAI-based regulatory compliance offering for life sciences.
In addition, QE&A highlights its customer experience assurance capabilities (UX testing, including accessibility). The practice targets businesses for UX testing rather than IT and has built the offering with Cognizant’s digital experience unit across consulting, design, and testing.
Of the above initiatives, AI and GenAI have been a priority for bringing further automation and productivity to QE.